Inspire

• 
• 
• 
• 
• 
• 

• • History
  • Leadership
  • Business Development
  • Community
  • Careers
  • Contact
  • Overview
  • AZASITE^®
  • ELESTAT^®
  • Pipeline
  • Research
  • Publications
  • Analyst Coverage
  • Contact
  • Corporate Governance
  • Events & Presentations
  • News
  • SEC Filings

PROLACRIA^TM (diquafosol tetrasodium ophthalmic solution 2%) for dry eye - Phase 3; Approvable

Phase 1 Trials

Phase 1 data presentations and peer-reviewed publications

Phase 2 Trials (Trial 03-103)

Press Release on Trial 03-103 results

Phase 2 data presentations and peer-reviewed publications

Phase 3 Trials (Trials 03-104, 03-105, 03-108, 03-109 and 03-113)

Press Release on Trial 03-104 results

Press Release on Trial 03-105 results

Press Release on Trial 03-108 results

Press Release on Trial 03-109 results

Press Release on Trial 03-113 results

Phase 3 data presentations and peer-reviewed publications

Pipeline Links